Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$140.9M
+109.2% from 2023
Prescriptions
1,192
$118,225.37 per claim
Patients
409
254 prescribers
Total spending, 2024
$140.9M
$344,559.04 per patient
Medicare prescription drug plans paid $140.9M for Amvuttra in 2024, for 1,192 prescriptions and refills to 409 patients (up 109.2% from 2023). The average cost per claim was $118,225.37.
New York had the highest Medicare cost for Amvuttra in 2024: $33.0M for 278 claims, followed by Florida ($15.8M).
David L Stern, cardiology in Great Neck, NY, had the highest Medicare cost for Amvuttra in 2024: 49 claims costing $6.0M.
Amvuttra is made by Alnylam Pharmaceuticals, Inc. (ALNY), listed in the Medicare spending data as Alnylam Pharmac.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| David L Stern Great Neck, NY | Cardiology | 49 | 17 | $6.0M |
| Hristelina S Ilieva Philadelphia, PA | Neurology | 32 | Under 11 | $3.8M |
| Sami L Khella |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 53 | 98 | 68 | $11.4M |
| 2023 | 136 | 562 | 195 | $67.4M |
| 2024 | 254 | 1,192 | 409 | $140.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 28 |
| Under 11 |
| $3.4M |
| Dalton S McLean Greensboro, NC | Advanced Heart Failure and Transplant Cardiology | 28 | Under 11 | $3.2M |
| John L Berk Boston, MA | Pulmonary Disease | 28 | 11 | $3.1M |
| Urvi G Desai Charlotte, NC | Neurology | 24 | Under 11 | $2.9M |
| Olakunle O Akinboboye Laurelton, NY | Cardiology | 19 | Under 11 | $2.2M |
| Thomas H Brannagan III New York, NY | Neurology | 17 | Under 11 | $2.0M |
| Sita Swamy Orlando, FL | Nurse Practitioner | 17 | Under 11 | $2.0M |
| Yessar M Hussain Austin, TX | Neurology | 17 | Under 11 | $1.9M |
| Brittany Stuart Brooklyn, NY | Physician Assistant | 16 | Under 11 | $1.9M |
| Subodh K Agrawal Athens, GA | Cardiology | 15 | Under 11 | $1.8M |
| Michelle Y Kaku New York, NY | Neurology | 14 | Under 11 | $1.7M |
| Elsy V Navas Naples, FL | Advanced Heart Failure and Transplant Cardiology | 14 | Under 11 | $1.7M |
| Vanessa Tiongson New York, NY | Neurology | 14 | Under 11 | $1.7M |
| Ashley M Bock Nashville, TN | Cardiology | 14 | Under 11 | $1.7M |
| Daniel P Judge Charleston, SC | Advanced Heart Failure and Transplant Cardiology | 15 | Under 11 | $1.7M |
| Jennifer M Lynch Hartsville, SC | Nurse Practitioner | 14 | Under 11 | $1.6M |
| Anju Bhardwaj Charlottesville, VA | Cardiology | 12 | Under 11 | $1.4M |
| Saurabh Malhotra Buffalo, NY | Cardiology | 12 | Under 11 | $1.4M |
| Sushma Koneru Orlando, FL | Advanced Heart Failure and Transplant Cardiology | 12 | Under 11 | $1.4M |
| Jan M Griffin Boston, MA | Advanced Heart Failure and Transplant Cardiology | 11 | Under 11 | $1.3M |
| Chafic Karam Portland, OR | Neurology | 11 | Under 11 | $1.2M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Alnylam Pharmac ALNY | 1,192 | $140.9M |